Choueiri TK - Search Results

1

The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine.

Harshman LC, Fougeray R, Choueiri TK, Schutz FA, Salhi Y, Rosenberg JE, Bellmunt J. Harshman LC, et al. Among authors: choueiri tk. Br J Cancer. 2013 Nov 12;109(10):2548-53. doi: 10.1038/bjc.2013.617. Epub 2013 Oct 15. Br J Cancer. 2013. PMID: 24129239 Free PMC article. Clinical Trial.

2

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.

Choueiri TK, Dreicer R, Rini BI, Elson P, Garcia JA, Thakkar SG, Baz RC, Mekhail TM, Jinks HA, Bukowski RM. Choueiri TK, et al. Cancer. 2006 Dec 1;107(11):2609-16. doi: 10.1002/cncr.22290. Cancer. 2006. PMID: 17075879 Free article. Clinical Trial.

3

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

Choueiri TK, Garcia JA, Elson P, Khasawneh M, Usman S, Golshayan AR, Baz RC, Wood L, Rini BI, Bukowski RM. Choueiri TK, et al. Cancer. 2007 Aug 1;110(3):543-50. doi: 10.1002/cncr.22827. Cancer. 2007. PMID: 17577222 Free article.

4

Factors associated with outcome in patients with advanced renal cell carcinoma in the era of antiangiogenic agents.

Choueiri TK. Choueiri TK. Clin Genitourin Cancer. 2008 Mar;6(1):15-20. doi: 10.3816/CGC.2008.n.002. Clin Genitourin Cancer. 2008. PMID: 18501077 Review.

5

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.

Choueiri TK, Xie W, D'Amico AV, Ross RW, Hu JC, Pomerantz M, Regan MM, Taplin ME, Kantoff PW, Sartor O, Oh WK. Choueiri TK, et al. Cancer. 2009 Mar 1;115(5):981-7. doi: 10.1002/cncr.24064. Cancer. 2009. PMID: 19152438 Free PMC article.

6

Treatment selection for patients with metastatic renal cell carcinoma.

Atkins MB, Choueiri TK, Cho D, Regan M, Signoretti S. Atkins MB, et al. Among authors: choueiri tk. Cancer. 2009 May 15;115(10 Suppl):2327-33. doi: 10.1002/cncr.24231. Cancer. 2009. PMID: 19402069 Free PMC article. Review.

7

Sunitinib in renal-cell carcinoma: expanded indications.

Choueiri TK, Bellmunt J. Choueiri TK, et al. Lancet Oncol. 2009 Aug;10(8):740. doi: 10.1016/S1470-2045(09)70185-8. Epub 2009 Jul 15. Lancet Oncol. 2009. PMID: 19615941 Review. No abstract available.

8

Recent progress and pitfalls in testing novel agents in castration-resistant prostate cancer.

Bellmunt J, Rosenberg JE, Choueiri TK. Bellmunt J, et al. Among authors: choueiri tk. Eur Urol. 2009 Oct;56(4):606-8. doi: 10.1016/j.eururo.2009.07.015. Epub 2009 Jul 22. Eur Urol. 2009. PMID: 19635642 No abstract available.

9

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials.

Je Y, Schutz FA, Choueiri TK. Je Y, et al. Among authors: choueiri tk. Lancet Oncol. 2009 Oct;10(10):967-74. doi: 10.1016/S1470-2045(09)70222-0. Epub 2009 Sep 18. Lancet Oncol. 2009. PMID: 19767240 Review.

10

Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence.

Nguyen PL, Chen MH, Beard CJ, Suh WW, Choueiri TK, Efstathiou JA, Hoffman KE, Loffredo M, Kantoff PW, D'Amico AV. Nguyen PL, et al. Among authors: choueiri tk. Cancer. 2010 Feb 1;116(3):610-5. doi: 10.1002/cncr.24818. Cancer. 2010. PMID: 19957321 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

819 results

Search Page

Filters